US authorizes COVID-19 booster shots for those with weak immune systems

Published: Updated:
Enable Read mode
100% Font Size

The US on Thursday authorized an extra dose of COVID-19 vaccine for people with weakened immune systems, as the country struggles to thwart the Delta variant.

For more coronavirus news, visit our dedicated page.

Emergency use authorization for a third injection of the Pfizer-BioNTech and Moderna vaccines was granted by the US Food and Drug Administration (FDA) regulator.

“The country has entered yet another wave of the COVID-19 pandemic, and the FDA is especially cognizant that immunocompromised people are particularly at risk for severe disease,” said acting FDA Commissioner Janet Woodcock in a statement.

“Other individuals who are fully vaccinated are adequately protected and do not need an additional dose of COVID-19 vaccine at this time,” she added.

The FDA said the additional dose was for solid organ transplant recipients or those with equivalent weakened immune systems.

US health authorities had been debating whether a third dose may be required, following a similar move by Israel.

More than 619,000 people have died in the US from COVID-19, with case numbers increasing sharply in recent months due to the spread of the Delta variant.

The country’s rapid vaccination program has slowed particularly in politically conservative regions in the South and Midwest, and among younger people, those with lower income and racial minorities.

Read more:

WHO calls on governments to cooperate to accelerate studies into origins of COVID-19

Booster shot will be recommended for weakened immune systems, says Dr. Fauci

US CDC recommends pregnant women get COVID-19 vaccine

Top Content Trending